title: Biochemical dynamics and hypocholesterolemic action of Hibiscus sabdariffa (Karkade).
abstract: Male albino rats were fed on a mixture of cholesterol and cholic acid for 12 weeks to induce hypercholesterolemia, then Karkade was administered at 5 and 10% for 9 weeks to evaluate its hypocholesterolemic and hypolipemic effect. The experimental parameters include total lipids, cholesterol, triglycerides and phospholipids. Liver and kidney functions were also investigated in normal, hypo- and hypercholesterolemic rats administered Karkade. A remarkable progress (lowering effect) in the level of different lipid fractions was noticed in spite of the continued cholesterol and cholic acid loading during the treatment. However, blood phospholipids were increased after Karkade administration. Hypercholesterolemia has resulted in an effect on the activity of liver and kidney functions. Therefore, the measurement of serum enzyme activity has provided a useful tool for hepatic recovery. Although the administration of Karkade at 5 and 10% induced a significant decrease in the activity of serum GOT and serum GPT, alkaline and acid phosphatase as well as total serum protein, the values nearly returned to the initial levels after 9 weeks of Karkade administration.
authors.affiliation: Biochemistry Department, Faculty of Agriculture, Zagazig University, Egypt.
authors.forename: S S
authors.initials: SS
authors.lastname: el-Saadany
authors.forename: M Z
authors.initials: MZ
authors.lastname: Sitohy
authors.forename: S M
authors.initials: SM
authors.lastname: Labib
authors.forename: R A
authors.initials: RA
authors.lastname: el-Massry
mesh_terms: D000135:Acid Phosphatase / Q000097:blood / Q000378:metabolism; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood / Q000378:metabolism; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001219:Aspartate Aminotransferases / Q000097:blood; D001923:Brain Chemistry / Q000187:drug effects; D002791:Cholesterol, Dietary / Q000494:pharmacology; D003404:Creatinine / Q000097:blood; D004032:Diet; D004534:Egypt; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010946:Plants, Medicinal / Q000737:chemistry*; D051381:Rats; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D014527:Uric Acid / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D008055:Lipids; D014527:Uric Acid; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase